Dificid (fidaxomicin)

pCPA File Number: 20718
Negotiation Status:
Concluded with an LOI
Indication(s):
Clostridium difficile infection
Sponsor/Manufacturer:
Optimer Pharmaceuticals
CDA-AMC Project Number:
SR0285-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: